Transfer of Obligation. II.10.1 The BSP can transfer in day-ahead or in intraday, for a certain quarter-hour, part or all of his aFRR Obligation to one or several Counterpart BSP(s) holding a valid BSP Contract aFRR to the date of the performance of the aFRR Obligation.
Transfer of Obligation. In accordance with Art. II.10, XXXX allows the BSP to transfer part or all of his aFRR Obligation to one or several Counterpart BSP(s). Similarly, the BSP may agree to make an additional aFRR Capacity available to XXXX as a result of a Transfer of Obligation from a Counterpart BSP to the BSP.
Transfer of Obligation. To the extent Business Associate is to carry out one or more of Covered Entity's obligation(s) under Subpart E of 45 C.F.R. Part 164, Business Associate must comply with the requirements of Subpart E that apply to the Covered Entity in the performance of such obligation(s);
Transfer of Obligation. See Work Statement NB-1 Attachment C. Attachment 2, Attachment H-1 Attachment 3 Form of Enterprise CTA CLINICAL TRIAL AGREEMENT Protocol No. BA058-05-003 This Clinical Trial Agreement (“Agreement”) is entered into by and among CENTER FOR CLINICAL AND BASIC RESEARCH A/S, Xxxxxxxxxxx 0, 0, 0000 Xxxxxxxx, Xxxxxxx (“CCBR”) on behalf of itself and its ten [affiliated][controlled] Clinical Study Sites listed below and Nordic Bioscience A/S, Xxxxxx Xxxxxxxxx 000, 0000 Xxxxxx, Xxxxxxx (“Nordic Bioscience”), representing the interests of Radius Health, Inc. (“Sponsor”) concerning: Protocol No. BA058-05-003, “A Randomized, Double-blind, Placebo-controlled, Comparative Phase 3 Multicenter Study to Evaluate the Safety and Efficacy of BA058 (“Study Drug”) for Injection for Prevention of Fracture in Ambulatory Postmenopausal Women with Severe Osteoporosis and at Risk of Fracture” (together with any of its subsequent amendments, the “Protocol”), which will guide the performance of the Study, has been prepared by Radius and Nordic Bioscience and accepted by the Clinical Study Sites. CCBR has the legal authority to bind the following clinical study sites (the “Clinical Study Site(s)”):
Transfer of Obligation. In accordance with 21CFR Part 312, Subpart D (responsibilities of Sponsor) Transfer of Obligations needs to be in written format and if decided upon by the AstraZeneca clinical team also be agreed at a more detailed level through a separate “Roles and Responsibility” document to be included/reflected in any clinical study agreement with the study sites and/or the CRO or other clinical research providers contracted for the purpose of the Initial Studies.
Transfer of Obligation. In accordance with Section 7.2(i), Seller shall take all action that is necessary to transfer and assign the responsibility for the assumption of any obligation for contributions to the GCIU Fund (defined and described in Section 7.2(i)) that accrue on and after the Closing Date to the Buyer, including, but no limited to, executing any documents, and providing information to Buyer to effectuate the assignment and the administration of such responsibility to Buyer.
Transfer of Obligation. The Option shall not be transferable by Option Holder except by his/her Last Will or the laws of the Holder's domicile at the time of his/her death relating to intestacy. During his/her lifetime, Option Holder is the only person who may exercise the Option. More specifically, without limiting the generality of the foregoing, the Option may not be assigned, transferred (except as permitted herein) pledged or hypothecated in any way, whether by operation of law or otherwise, and shall not be subject to execution, attachment or similar process. Any attempted assignment, transfer, pledge, hypothecation or other disposition of the Option contrary to the provisions hereof, and the levy of any attachment or similar process on the Option shall be null and void and without effect.
Transfer of Obligation. The covenants and conditions of this Lease shall be binding upon the heirs, legal representatives, successors and agreed assigns of any or all the Parties hereto.
Transfer of Obligation. A. Subdivider acknowledges and agrees that no delegation of performance required by this Agreement relieves the Subdivider of any duty to perform or any liability for the breach of that duty to complete the Improvements required for the Xxxxx Xxxxxxxxxx Xxxxxxxx Xxxxx 0
Transfer of Obligation. In accordance with Art. II.9, XXXX allows the BSP to transfer part or all of his mFRR Obligation to one or several Counterpart BSP(s). Similarly, the BSP may agree to make an additional mFRR Capacity available to XXXX as a result of a Transfer of Obligation from a Counterpart BSP to the BSP. This annex lays down the conditions under which the Transfer of Obligation may apply and defines the rules and procedure that XXXX, the BSP and the Counterpart BSP must respect in order to notify and validate said transfers.
